Stanford doctor’s stock raises ethics concerns

June 26, 2008

A Stanford Medical School psychiatrist has vastly underreported his investment in a drug company whose fortunes could be affected by the university’s studies, contends Sen. Charles Grassley of Iowa, the ranking Republican on the Senate Finance Committee. (San Jose Mercury)